• PRDX5 Acetylation in Retinal Ischemia–Reperfusion

  2026-08-24

  The reference study identifies PRDX5 acetylation as a regulatory mechanism that weakens antioxidant and anti-apoptotic protection during retinal ischemia–reperfusion injury. Using an acute high intraocular pressure mouse model and OGD/R-treated R28 cells, the authors connect PRDX5 abundance and acetylation status with oxidative stress, mitochondrial dysfunction, and neuronal apoptosis.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-08-24

  A 2026 Free Radical Biology and Medicine study identifies O-GlcNAcylated HUWE1 as a regulatory link between trophoblast iron uptake, ferroptosis, and syncytialization in preeclampsia. The work proposes that increasing O-GlcNAc modification stabilizes HUWE1, promotes TfR1 ubiquitination and degradation, and limits iron-driven placental injury.

• GKT137831 for Nox1/Nox4 Redox Workflows

  2026-08-23

  GKT137831 is a dual NADPH oxidase Nox1/Nox4 inhibitor for separating enzyme-derived oxidative signaling from downstream membrane injury. This workflow-focused guide shows how to apply it in vascular, fibrosis, atherosclerosis, and ferroptosis-adjacent assays while avoiding overinterpretation.

• Indometacin Sodium: Applied Research Workflows

  2026-08-22

  Indometacin Sodium supports controlled COX inhibition, prostaglandin synthesis inhibition, follicle-rupture studies, and differentiation assays in one adaptable research workflow. This guide translates randomized IVF evidence and product-specific concentration data into practical setup, optimization, and troubleshooting decisions.

• AG-490: A Causal Probe of JAK2/STAT6 Biology

  2026-08-22

  AG-490, or Tyrphostin B42, can help researchers interrogate how JAK2-linked signaling shapes tumor-associated macrophage states. This article emphasizes causal assay design, pathway attribution, and the limitations of translating exosomal SNORD52 findings into pharmacological experiments.

• NS1–DNMT1 Control of HBoV1 Replication

  2026-08-21

  A 2024 PLOS Pathogens study identifies DNMT1-dependent DNA methylation as a regulator of human bocavirus 1 replication and RNA processing. It further shows that the viral NS1 protein promotes DNMT1 degradation through the ubiquitin–proteasome pathway, revealing a mechanistic connection between viral DNA synthesis, transcript maturation, and host epigenetic control.

• Triptolide (PG490): Mechanisms and Research Use

  2026-08-20

  Triptolide, also known as PG490, is a nanomolar-potency natural product used in cancer research, immunology, and inflammation studies. Its reported actions include IL-2 suppression, NF-κB transcriptional inhibition, CDK7-associated RNA polymerase II loss, matrix metalloproteinase reduction, and apoptosis induction.

• Anlotinib in Desmoplastic Small Round Cell Tumors

  2026-08-20

  This case report and literature review describes the first reported clinical use of anlotinib for metastatic intra-abdominal desmoplastic small round cell tumor, with marked reduction of metastatic lymph nodes after four treatment cycles and tolerable fatigue and hypertriglyceridemia. The report is hypothesis-generating rather than confirmatory, but it shows how a multi-target tyrosine kinase inhibitor may provide a treatment option when standard multimodal therapy fails.

• Oligomycin A for Mitochondrial Bioenergetics

  2026-08-19

  Oligomycin A provides a controlled way to separate ATP-linked respiration from broader metabolic stress in cell and cancer models. This practical guide connects mitochondrial flux assays with ROS, viability, and macrophage immunometabolism workflows while emphasizing solvent control and interpretation limits.

• Berbamine hydrochloride: HCC Assay Workflows

  2026-08-19

  Build reproducible cancer research workflows around Berbamine hydrochloride by combining pathway readouts, dose-response profiling, and ferroptosis-focused validation. The approach distinguishes direct viability effects from changes in NF-κB, STAT3, calcium, iron, and lipid-peroxidation biology.

• HDAC8, AKT, and Resistance to MEK Inhibition

  2026-08-18

  The reference study identifies an HDAC8–PLCB1/DESC1 regulatory axis that activates AKT when MEK1/2–ERK signaling is inhibited in colorectal cancer and melanoma models. Its combination of transcriptomic discovery and causal perturbation suggests that resistance may be addressed by targeting compensatory signaling rather than intensifying MEK inhibition alone.

• CDC42, NTCP Trafficking, and HBV Entry

  2026-08-18

  The reference study identifies CDC42 as a regulator of hepatitis B virus entry through two separable mechanisms: Rab11-dependent delivery of NTCP to the plasma membrane and CDC42-dependent macropinocytosis. These findings expand the conventional model of HBV uptake beyond clathrin-mediated endocytosis and highlight receptor trafficking as a determinant of hepatocyte susceptibility.

• γH2AX DNA Damage Detection Kit for DSB Research

  2026-08-17

  Translate radiation, drug, and genotoxic stress into a measurable nuclear signal with the γH2AX DNA Damage Detection Kit. Its red Cy5 γ-H2AX foci and blue DAPI counterstain support microscopy, repair-kinetics studies, and high-content comparisons such as FLASH-RT radiosensitization.

• Firefly Luciferase mRNA Workflow

  2026-08-17

  Build more interpretable mRNA delivery screens with a Cap1-capped, 5-moUTP modified reporter that separates transcript performance from carrier effects. The workflow combines controlled handling, functional luminescence readouts, and low-cost mixer comparisons for cell-based assays and carefully qualified imaging studies.

• Pioglitazone (B2117) for Reliable Cell Assays

  2026-08-16

  Learn how Pioglitazone (SKU B2117) can improve interpretation of viability, proliferation, and inflammatory-cell assays through controlled PPARγ activation, solvent handling, and orthogonal validation. This scenario-based guide connects receptor pharmacology with practical workflows in metabolic and inflammation research.

678 records 1/46 page Next 12345 下5页 Last page